10 completed, 1 withdrawn. 6 Phase 3, 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 5, Withdrawn 1 |
| Phase 1 | 5 | Completed 5 |
Follow Insulin Peglispro: new trials by email Literature Review of Insulin Peglispro trials Research Report on Insulin Peglispro
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus Insulin Peglispro, Insulin Glargine - Diabetes Mellitus, Type 2 | Phase 3 | Withdrawn | Eli Lilly and Company | 2015-02-01 | 2016-03-28 | |
| A Study To Compare the Effects of Insulin Peglispro and Glargine on Insulin Sensitivity and Meal Time Insulin Requirements in Type 2 Diabetics Insulin Peglispro, Insulin Glargine, Insulin Lispro - Diabetes Mellitus, Type 2 | Phase 1 | Completed | Eli Lilly and Company | 24 | 2014-07-01 | 2018-11-01 |
| A Study to Compare and Measure the Effects of Insulin Peglispro (LY2605541) and Glargine on Meal Time Insulin Requirements Insulin Peglispro, Insulin Lispro, Insulin Glargine - Diabetes Mellitus, Type 1 | Phase 1 | Completed | Eli Lilly and Company | 28 | 2014-06-01 | 2019-03-01 |
| A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 Diabetes Insulin Peglispro, Insulin Glargine - Type 2 Diabetes Mellitus | Phase 3 | Completed | Eli Lilly and Company | 68 | 2014-05-01 | 2019-09-18 |
| A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat Tissue Insulin Peglispro, Human Insulin - Diabetes Mellitus, Type 1 | Phase 1 | Completed | Eli Lilly and Company | 24 | 2014-04-01 | 2019-03-06 |
| A Study of Insulin Peglispro in Healthy Male Japanese Participants Insulin Peglispro - Healthy Volunteers | Phase 1 | Completed | Eli Lilly and Company | 11 | 2013-12-01 | 2018-10-19 |
| A Study of Insulin Peglispro and Glargine on Fats in Participants With Type 1 Diabetes Insulin Peglispro, Insulin Glargine - Diabetes Mellitus, Type 1 | Phase 1 | Completed | Eli Lilly and Company | 15 | 2013-10-01 | 2019-03-11 |
| A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin Treatment Insulin Peglispro, Insulin Glargine, Oral Antihyperglycemic Medications (OAMs) - Type 2 Diabetes Mellitus | Phase 3 | Completed | Eli Lilly and Company | 388 | 2013-07-01 | 2019-03-15 |
| A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus LY2605541, Insulin Lispro - Type 1 Diabetes Mellitus | Phase 3 | Completed | Eli Lilly and Company | 212 | 2013-02-01 | 2018-04-20 |
| A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus LY2605541, Insulin glargine - Diabetes Mellitus, Type 2 | Phase 3 | Completed | Eli Lilly and Company | 466 | 2012-05-01 | 2018-04-20 |
| A Study in Participants With Type 2 Diabetes Mellitus LY2605541, Insulin Glargine, Insulin Lispro - Diabetes Mellitus, Type 2 | Phase 3 | Completed | Eli Lilly and Company | 1369 | 2011-12-01 | 2018-04-17 |
Diabetes Mellitus, Type 2 (6) · Diabetes Mellitus, Type 1 (4)
United States (6) · Germany (4) · Japan (3) · Puerto Rico (3) · Austria (2) · Czechia (2) · Denmark (2) · Greece (2) · Israel (2) · Romania (2) · Russia (2) · Spain (2) · Taiwan (2) · Australia (1) · Brazil (1)
PMID 36542287, PMID 26577417, PMID 28417532, PMID 28587667, PMID 29167192